| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Hyperlipidemias | D006949 | 73 associated lipids |
Total
4
1-octadecanoyl-sn-glycero-3-phosphocholine
1-octadecanoyl-sn-glycero-3-phosphocholine is a lipid of Glycerophospholipids (GP) class. 1-octadecanoyl-sn-glycero-3-phosphocholine is associated with abnormalities such as Septicemia. The involved functions are known as Phosphorylation, MAP kinase activity, Phagocytosis, protein serine/threonine kinase activity and Uptake. The associated genes with 1-octadecanoyl-sn-glycero-3-phosphocholine are FPR1 gene and OLR1 gene. The related lipids are Lysophosphatidylcholines.
Cross Reference
Introduction
To understand associated biological information of 1-octadecanoyl-sn-glycero-3-phosphocholine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?
1-octadecanoyl-sn-glycero-3-phosphocholine is suspected in Septicemia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 1-octadecanoyl-sn-glycero-3-phosphocholine
PubChem Associated disorders and diseases
What pathways are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?
There are no associated biomedical information in the current reference collection.
What functions are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 1-octadecanoyl-sn-glycero-3-phosphocholine?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 1-octadecanoyl-sn-glycero-3-phosphocholine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Shi AH et al. | Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes. | 1999 | Horm. Metab. Res. | pmid:10333086 |
| Shi A et al. | Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol. | 1999 | Exp. Clin. Endocrinol. Diabetes | pmid:10543409 |
| Asai Y et al. | Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0). | 2000 | Drug Dev Ind Pharm | pmid:10826115 |
| Mansfield PJ et al. | Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D. | 2002 | Blood | pmid:11830497 |
| Sonoki K et al. | Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. | 2003 | Metab. Clin. Exp. | pmid:12647268 |
| Vesterqvist O et al. | Quantitation of lysophosphatidylcholine molecular species in rat cardiac tissue. | 1992 | Anal. Biochem. | pmid:1514697 |
| Soga T et al. | Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15607732 |
| Chen G et al. | Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. | 2005 | J. Lipid Res. | pmid:15687351 |
| Tang D et al. | Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. | 2009 | Am. J. Respir. Cell Mol. Biol. | pmid:19265175 |